Login / Signup
Tocilizumab for refractory rapidly progressive interstitial lung disease related to anti-MDA5-positive dermatomyositis.
Xiao Zhang
Shuang Zhou
Chanyuan Wu
Meng Tao Li
Qian Wang
Yan Zhao
Xiao-Feng Zeng
Published in:
Rheumatology (Oxford, England) (2021)
Keyphrases
</>
interstitial lung disease
rheumatoid arthritis
systemic sclerosis
idiopathic pulmonary fibrosis
multiple sclerosis
disease activity
breast cancer cells
juvenile idiopathic arthritis
rheumatoid arthritis patients
signaling pathway
cell cycle arrest
systemic lupus erythematosus
drug induced